[EATG Global HIV News daily digest] Digest #35-2010

[EATG Global HIV News daily digest]

Global HIV News Daily Digest

Copied as fair use  -  Ana  -



Latest Headlines




  Avila aims to trump Vertex with drug that hits hepatitis C virus and won’t let go
  Hepatitis Friday 26 February 2010
					
  
Avila Therapeutics can’t be accused of thinking too small. This
Waltham, MA-based startup is on a quest to show it has the scientific
chops to build a better drug than one of Boston’s anchor biotech
companies—Vertex Pharmaceuticals.
  SOURCE:
Xconomy




  Resistance likely to develop with new hepatitis C drugs
  Hepatitis Friday 26 February 2010
					
  
Addition of drugs to interferon and ribavirin treatment improves efficacy.
  SOURCE:
ModernMedicine




  Circumcision: Zimbabwe's latest anti-HIV weapon 
  Prevention Friday 26 February 2010
					
  
Lovemore bravely looks on at the work of the doctor and nurse as they perform the circumcision.
  SOURCE:
BBC News




  Research sheds new light on HIV in the gut
  Treatment Friday 26 February 2010
					
  
Different forms of HIV genetic material are concentrated in different
parts of the gastrointestinal tract, and HIV behavior and immune
response appears different in the gut than in the blood.
  SOURCE:
HIVandHepatitis.com




  A ‘test and treat’ approach to fighting HIV
  Prevention Friday 26 February 2010
					
  
A promising new way to prevent the spread of HIV is being tested in
Botswana on a group of people who are being exposed to a particularly
vicious strain of the virus. They are now being treated with strong
antiretroviral drugs.
  SOURCE:
Boston.com




  Drug-resistant malaria 'growing' in Cambodia 
  Tuberculosis & Malaria Friday 26 February 2010
					
  
Parasites are developing resistance to one of the most important anti-malaria drugs, according to experts.
  SOURCE:
BBC News




  Thai govt policies are killing local pharma, says industry  
  Pharma Industry Friday 26 February 2010
					
  
Drugmakers in Thailand have urged the government to revoke the “special
privileges” granted to the Government Pharmaceutical Organisation
(GPO), claiming that these are unfair and destroying the domestic
commercial industry.
  SOURCE:
PharmaTimes




  New drug prices in Australia “lowest in developed world”  
  Access to treatment Friday 26 February 2010
					
  
Australia pays the lowest prices for new drugs in the developed world,
but for a number of high-volume drugs, prices there are higher than in
the UK, recent data shows.
  SOURCE:
PharmaTimes




  Individuals who naturally lack CCR5 receptor have resistant to HIV
  Basic Science Friday 26 February 2010
					
  
Researchers successfully removed CCR5 - a cell receptor to which HIV-1
binds for infection but which the human body does not need - from human
cells. Individuals who naturally lack the CCR5 receptor have been found
to be essentially resistant to HIV. 
  SOURCE:
The Medical News




  Ten-year sentence in Scottish HIV prosecution 
  World Policy Friday 26 February 2010
					
  
An HIV-positive man in Scotland has been sentenced to ten years in jail
after being convicted of infecting one female partner with HIV and
having unprotected sex with three other women without disclosing his
HIV status. 
  SOURCE:
Aidsmap




  Suppressive antiretroviral therapy slows progression of atherosclerosis 
  Treatment Friday 26 February 2010
					
  
Antiretroviral therapy that reduces viral load to an undetectable level
was linked to slower progression of sub-clinical atherosclerosis.
  SOURCE:
Aidsmap




  CD4 counts declining more rapidly among recent seroconverters in US military cohort 
  Treatment Friday 26 February 2010
					
  
In a study of over 1000 mostly male seroconverters in the United States
military, CD4 cell counts appear to be declining more quickly in those
who seroconverted in more recent years.
  SOURCE:
Aidsmap


----------------------------------------------------
DISCLAIMER
The articles in this digest represent a diversity of opinions on topics
of interest to the HIV treatment activist community. The EATG is not
responsible for their content. The articles posted in this digest do
not necessarily reflect EATG views or opinions.
FAIR USE NOTICE
The digest may contain copyrighted material which has not always been
specifically authorised by the copyright owner. Such material is made
available for educational purposes to advance the understanding of
scientific, ethical, legal and social issues. It is believed that this
constitutes a 'fair use' of any such copyrighted material. This
material is distributed without profit.


 

Information in this digest was accurately quoted during its compilation.




      
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://mail.eatg.org/pipermail/eatg-forum_eatg.org/attachments/20100226/8913a025/attachment-0001.html>